CLYM vs NWSA · $85.8M cap vs rev $9.03B
Climb Bio Inc (CLYM) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Climb Bio Inc (CLYM) is a biotechnology company listed on US.
NWSA (NWSA) common stock.
CLYM does not have a complete income-statement cache yet.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
CLYM currently screens at market cap $85.8M. NWSA currently screens at market cap $0.
Not investment advice. Open the CLYM and NWSA stock pages for the full models.
Not investment advice.